1. Home
  2. GLPG vs MAN Comparison

GLPG vs MAN Comparison

Compare GLPG & MAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLPG
  • MAN
  • Stock Information
  • Founded
  • GLPG 1999
  • MAN 1948
  • Country
  • GLPG Belgium
  • MAN United States
  • Employees
  • GLPG N/A
  • MAN N/A
  • Industry
  • GLPG Biotechnology: Pharmaceutical Preparations
  • MAN Professional Services
  • Sector
  • GLPG Health Care
  • MAN Consumer Discretionary
  • Exchange
  • GLPG Nasdaq
  • MAN Nasdaq
  • Market Cap
  • GLPG 1.8B
  • MAN 2.0B
  • IPO Year
  • GLPG 2005
  • MAN 1988
  • Fundamental
  • Price
  • GLPG $27.87
  • MAN $40.70
  • Analyst Decision
  • GLPG Sell
  • MAN Hold
  • Analyst Count
  • GLPG 4
  • MAN 5
  • Target Price
  • GLPG $25.33
  • MAN $50.60
  • AVG Volume (30 Days)
  • GLPG 259.2K
  • MAN 859.2K
  • Earning Date
  • GLPG 07-23-2025
  • MAN 07-17-2025
  • Dividend Yield
  • GLPG N/A
  • MAN 5.66%
  • EPS Growth
  • GLPG N/A
  • MAN 129.57
  • EPS
  • GLPG N/A
  • MAN 2.33
  • Revenue
  • GLPG $311,493,731.00
  • MAN $17,540,900,000.00
  • Revenue This Year
  • GLPG $0.78
  • MAN N/A
  • Revenue Next Year
  • GLPG N/A
  • MAN $2.56
  • P/E Ratio
  • GLPG N/A
  • MAN $17.10
  • Revenue Growth
  • GLPG 18.32
  • MAN N/A
  • 52 Week Low
  • GLPG $22.36
  • MAN $37.99
  • 52 Week High
  • GLPG $31.23
  • MAN $78.22
  • Technical
  • Relative Strength Index (RSI)
  • GLPG 51.86
  • MAN 47.61
  • Support Level
  • GLPG $26.62
  • MAN $37.99
  • Resistance Level
  • GLPG $29.28
  • MAN $40.09
  • Average True Range (ATR)
  • GLPG 0.58
  • MAN 1.33
  • MACD
  • GLPG -0.16
  • MAN 0.06
  • Stochastic Oscillator
  • GLPG 54.51
  • MAN 51.52

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

About MAN ManpowerGroup

ManpowerGroup Inc. is engaged in providing workforce solutions and services. The company provides services that include Recruitment and Assessment, Upskilling, Reskilling, Training and Development, Career Management, Outsourcing, and Workforce Consulting. The reportable segments of the company are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others. The Staffing and Interim segment derives the maximum of the company's revenue. The company derives maximum geographical revenue from the Southern European region.

Share on Social Networks: